DECREASED SYNTHESIS OF HIGH-MOLECULAR-WEIGHT GLYCOPEPTIDES IN HUMAN PROMYELOCYTIC LEUKEMIC-CELLS (HL-60) DURING PHORBOL ESTER-INDUCED MACROPHAGE DIFFERENTIATION
- 1 January 1982
- journal article
- research article
- Vol. 42 (2), 484-489
Abstract
The human promyelocytic leukemia cell line, HL-60, synthesized a class of high MW (5000-7000), N-linked glycopeptides as the major class of protein-bound carbohydrates. Small glycopeptides (MW 2500-3500), typical of most mammalian cells except erythrocytes, represented a minor component in these cells. The large glycopeptides were labeled efficiently with fucose, glucosamine and galactose but only poorly with mannose. They were found not to be glycolipids, glycosaminoglycans, or mucin-type glycopeptides and were not susceptible to exoglycosidases, but they were partially degraded by endo-.beta.-galactosidase. These characteristics are similar to those of the large glycopeptides synthesized by erythrocytes, by another human myeloid leukemia cell line (K562), and by human and murine teratocarcinoma cells. High-molecular-weight glycopeptides predominated on another human myeloid leukemia cell line KG1, but they were expressed at low levels on both a human monocytic leukemia cell line (THP-1) and a human T-lymphoblastoid cell line (Jurkat). When HL-60 cells were induced to differentiate into macrophage-like cells with phorbol esters, the proportion of large glycopeptides decreased, and the production of small glycopeptides predominated. This shift was observed within the first several hours after exposure to phorbol esters and was temporally related to the acquisition of adherent properties by the induced cells. In contrast, when HL-60 cells were induced to differentiate into granulocytes by dimethyl sulfoxide, hypoxanthine or retinoic acid, they continued to synthesize glycopeptides similar to uninduced cells. Human peripheral blood granulocytes synthesized primarily large glycopeptides, whereas monocytes and lymphocytes synthesized mostly small glycopeptides. Apparently, the synthesis of high-molecular-weight glycopeptides is a property of human myeloid leukemia cell lines and that it persists throughout myeloid differentiation. A proportionate decrease in the synthesis of these large glycopeptides is a part of the differentiation program for monocytes and macrophages.This publication has 19 references indexed in Scilit:
- Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)International Journal of Cancer, 1980
- HUMAN MYELOID-LEUKEMIA CELL-LINES - A REVIEW1980
- Distinctive properties of fucosyl glycopeptides on human teratoma cellsSomatic Cell and Molecular Genetics, 1979
- Characterization of glycopeptides isolated from membranes of F9 embryonal carcinoma cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Specific changes in the surface glycoprotein pattern of human promyelocytic leukemic cell line HL-60 during morphologic and functional differentiation.Proceedings of the National Academy of Sciences, 1979
- Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.Proceedings of the National Academy of Sciences, 1979
- Glycopeptide changes and malignant transformation a possible role for cabohydrate in malignant behaviorBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1978
- Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cellsCell, 1978
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.Proceedings of the National Academy of Sciences, 1978
- Endo-beta-galactosidase of Escherichia freundii. Purification and endoglycosidic action on keratan sulfates, oligosaccharides, and blood group active glycoprotein.Journal of Biological Chemistry, 1976